Management to host conference call and webcast at 4:30 pm ET on that day
Boca Raton, Florida, July 27, 2022 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ:INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness a patient’s innate immune system to fight disease, today announced that it will host a conference call on Wednesday, August 3, 2022 at 4:30 PM Eastern Time to discuss results for its second quarter ended June 30, 2022 and to provide a corporate update.
Read more at globenewswire.com